Denis Billen

Title: Denis Billen - Innovator in Pharmaceutical Chemistry

Introduction

Denis Billen is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of receptor antagonists. His work is characterized by a focus on innovative methods that enhance the efficacy of pharmaceutical compounds.

Latest Patents

Denis Billen holds a patent for a process of making a crystalline EDG-2 receptor antagonist. This patent, titled "Process of making a crystalline EDG-2 receptor antagonist," describes methods for producing crystalline Form 1 of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid. This invention is crucial for advancing therapeutic options in treating various conditions.

Career Highlights

Denis is currently employed at Horizon Therapeutics Ireland DAC, where he continues to push the boundaries of pharmaceutical research. His work at Horizon Therapeutics has allowed him to collaborate with other talented professionals in the industry, contributing to the development of innovative treatments.

Collaborations

Denis has worked alongside esteemed colleagues such as Bênédicte Martin and Michelle O'Mahony. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Denis Billen is a prominent figure in the field of pharmaceutical chemistry, with a focus on innovative receptor antagonists. His contributions, particularly through his patent, demonstrate his commitment to advancing medical science. His work at Horizon Therapeutics and collaborations with talented colleagues highlight the importance of teamwork in driving innovation.